Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118275034 | 11827503 | 4 | F | 20160909 | 20151211 | 20160916 | PER | CA-AMGEN-CANSP2015131851 | AMGEN | 63.00 | YR | A | F | Y | 0.00000 | 20160916 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118275034 | 11827503 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | U | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 118275034 | 11827503 | 2 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 118275034 | 11827503 | 3 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 118275034 | 11827503 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 118275034 | 11827503 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 118275034 | 11827503 | 6 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 3 MG/KG, UNK | 0 | 3 | MG/KG | ||||||||
| 118275034 | 11827503 | 7 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | UNK | 0 | ||||||||||
| 118275034 | 11827503 | 8 | SS | NEORAL | CYCLOSPORINE | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 118275034 | 11827503 | 9 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 118275034 | 11827503 | 10 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 8 MG/KG, UNK | 0 | 8 | MG/KG | ||||||||
| 118275034 | 11827503 | 11 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | 125 MG, UNK | 0 | 125 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118275034 | 11827503 | 1 | Rheumatoid arthritis |
| 118275034 | 11827503 | 2 | Rheumatoid arthritis |
| 118275034 | 11827503 | 4 | Rheumatoid arthritis |
| 118275034 | 11827503 | 6 | Rheumatoid arthritis |
| 118275034 | 11827503 | 7 | Product used for unknown indication |
| 118275034 | 11827503 | 9 | Product used for unknown indication |
| 118275034 | 11827503 | 10 | Rheumatoid arthritis |
| 118275034 | 11827503 | 11 | Rheumatoid arthritis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118275034 | 11827503 | Drug ineffective | |
| 118275034 | 11827503 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118275034 | 11827503 | 1 | 200311 | 200401 | 0 | |
| 118275034 | 11827503 | 2 | 2000 | 0 | ||
| 118275034 | 11827503 | 3 | 2015 | 0 | ||
| 118275034 | 11827503 | 4 | 2000 | 0 | ||
| 118275034 | 11827503 | 5 | 2015 | 0 | ||
| 118275034 | 11827503 | 6 | 2002 | 2013 | 0 | |
| 118275034 | 11827503 | 7 | 2000 | 0 | ||
| 118275034 | 11827503 | 8 | 2015 | 0 | ||
| 118275034 | 11827503 | 10 | 201207 | 201209 | 0 | |
| 118275034 | 11827503 | 11 | 201301 | 201303 | 0 |